Express Scripts Holding Company Stock Price and Value Analysis

Should you buy Express Scripts Holding Company stock? (NasdaqGS:ESRX). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company is very stable.
  • This company has stable growth.
  • This company is not making money.
  • This stock looks overpriced.
  • This company pays no dividend.

ESRX Free Cash Flow Trend

Hmm, we can't give any reliable projection for Express Scripts Holding Company's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for ESRX
Free Cash Flow trendline for Express Scripts Holding Company

Inside the ESRX Numbers

ESRX Price
(Express Scripts Holding Company stock price per share)
$98.20
[?] PE Ratio versus Sector 53% lower than other Healthcare stocks
[?] PE Ratio versus Industry 20% lower than other Health Care Plans stocks
[?] Cash Yield 10.92%
[?] Free Cash Flow Jitter 21%

Is Express Scripts Holding Company Stock on Sale?

Based on our analysis, we believe that you should not buy Express Scripts Holding Company right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ESRX Stock?

Does Express Scripts Holding Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Stockalyzer::Template::Plugin::Bootstrap=HASH(0x7a1cae0) 8